Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia
出版年份 2013 全文链接
标题
Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 6, Pages e66755
出版商
Public Library of Science (PLoS)
发表日期
2013-06-25
DOI
10.1371/journal.pone.0066755
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- p85α SH2 Domain Phosphorylation by IKK Promotes Feedback Inhibition of PI3K and Akt in Response to Cellular Starvation
- (2012) William C. Comb et al. MOLECULAR CELL
- Impact ofBCR-ABLmutations on patients with chronic myeloid leukemia
- (2011) Andreas Hochhaus et al. CELL CYCLE
- In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
- (2011) Matthew P. Patricelli et al. CHEMISTRY & BIOLOGY
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells
- (2011) Peter P. Ruvolo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Quantitative Chemical Proteomics Reveals New Potential Drug Targets in Head and Neck Cancer
- (2011) Zhixiang Wu et al. MOLECULAR & CELLULAR PROTEOMICS
- Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer
- (2011) D. Gioeli et al. MOLECULAR CANCER THERAPEUTICS
- Survey of Activated FLT3 Signaling in Leukemia
- (2011) Ting-lei Gu et al. PLoS One
- Multicolor Monitoring of Dysregulated Protein Kinases in Chronic Myelogenous Leukemia
- (2010) Qunzhao Wang et al. ACS Chemical Biology
- Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
- (2010) N. Fenouille et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response
- (2010) C. A. Pratilas et al. CLINICAL CANCER RESEARCH
- Proteomics Analysis of Cellular Imatinib Targets and their Candidate Downstream Effectors
- (2010) Susanne B. Breitkopf et al. JOURNAL OF PROTEOME RESEARCH
- Chronic Myeloid Leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 Activity
- (2010) J R Engler et al. LEUKEMIA
- Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene
- (2010) C Nishioka et al. LEUKEMIA
- Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients
- (2010) Sandrine Hayette et al. LEUKEMIA RESEARCH
- Addressing Accuracy and Precision Issues in iTRAQ Quantitation
- (2010) Natasha A. Karp et al. MOLECULAR & CELLULAR PROTEOMICS
- Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
- (2010) E. I. Zimmerman et al. MOLECULAR PHARMACOLOGY
- Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC–MS/MS
- (2010) Richard D Unwin et al. Nature Protocols
- IKK-dependent, NF-κB-independent control of autophagic gene expression
- (2010) W C Comb et al. ONCOGENE
- Cause and management of therapy resistance
- (2009) Andreas Hochhaus et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
- (2009) I. Skorta et al. CANCER RESEARCH
- Multiple roles of Lyn kinase in myeloid cell signaling and function
- (2009) Patrizia Scapini et al. IMMUNOLOGICAL REVIEWS
- iTRAQ Underestimation in Simple and Complex Mixtures: “The Good, the Bad and the Ugly”
- (2009) Saw Yen Ow et al. JOURNAL OF PROTEOME RESEARCH
- The gatekeeper mutation T315I confers resistance against small molecules by increasing or restoring the ABL-kinase activity accompanied by aberrant transphosphorylation of endogenous BCR, even in loss-of-function mutants of BCR/ABL
- (2009) A A Mian et al. LEUKEMIA
- Large-scale Proteomics Analysis of the Human Kinome
- (2009) Felix S. Oppermann et al. MOLECULAR & CELLULAR PROTEOMICS
- Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors
- (2009) S. Grosso et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of Annexin A1 in Multidrug Resistance of K562/ADR Cells Identified by the Proteomic Study
- (2009) Fengjia Zhu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin
- (2009) Brian K. Bednarski et al. PLoS One
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
- Molecular biology of bcr-abl1-positive chronic myeloid leukemia
- (2008) A. Quintas-Cardama et al. BLOOD
- Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells
- (2008) J. Wu et al. BLOOD
- Persistent LYN Signaling in Imatinib-Resistant, BCR-ABL–Independent Chronic Myelogenous Leukemia
- (2008) Thomas O'Hare et al. JNCI-Journal of the National Cancer Institute
- I B kinase inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL+ cells
- (2008) E. A. Duncan et al. MOLECULAR CANCER THERAPEUTICS
- Kinase-Selective Enrichment Enables Quantitative Phosphoproteomics of the Kinome across the Cell Cycle
- (2008) Henrik Daub et al. MOLECULAR CELL
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259
- (2008) T Pene-Dumitrescu et al. ONCOGENE
- Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance
- (2008) Marion Pocaly et al. PROTEOMICS
- Src family kinases: Regulation of their activities, levels and identification of new pathways
- (2007) Evan Ingley BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Overcoming kinase resistance in chronic myeloid leukemia
- (2007) Francis Lee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started